Two Sigma Investments’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.9K Sell
11,299
-6,987
-38% -$21.6K ﹤0.01% 3041
2025
Q1
$63.8K Sell
18,286
-11,200
-38% -$39.1K ﹤0.01% 2958
2024
Q4
$96.4K Sell
29,486
-240
-0.8% -$785 ﹤0.01% 2907
2024
Q3
$114K Buy
29,726
+14,840
+100% +$57.1K ﹤0.01% 2819
2024
Q2
$46K Sell
14,886
-83,030
-85% -$257K ﹤0.01% 2813
2024
Q1
$253K Sell
97,916
-105,919
-52% -$273K ﹤0.01% 2557
2023
Q4
$510K Buy
203,835
+178,523
+705% +$446K ﹤0.01% 2371
2023
Q3
$51.4K Sell
25,312
-35,991
-59% -$73.1K ﹤0.01% 2734
2023
Q2
$141K Sell
61,303
-308,474
-83% -$709K ﹤0.01% 2630
2023
Q1
$1.12M Buy
+369,777
New +$1.12M ﹤0.01% 1735
2022
Q4
Sell
-24,442
Closed -$47K 2709
2022
Q3
$47K Buy
+24,442
New +$47K ﹤0.01% 2273
2022
Q2
Sell
-119,081
Closed -$355K 2380
2022
Q1
$355K Sell
119,081
-766,456
-87% -$2.28M ﹤0.01% 2119
2021
Q4
$3.45M Buy
885,537
+155,239
+21% +$604K 0.01% 1075
2021
Q3
$3.13M Buy
730,298
+476,475
+188% +$2.04M 0.01% 1129
2021
Q2
$769K Sell
253,823
-515,228
-67% -$1.56M ﹤0.01% 1801
2021
Q1
$2.56M Buy
+769,051
New +$2.56M 0.01% 1145
2020
Q3
Sell
-283,507
Closed -$516K 1829
2020
Q2
$516K Buy
283,507
+71,107
+33% +$129K ﹤0.01% 1413
2020
Q1
$215K Buy
212,400
+121,536
+134% +$123K ﹤0.01% 1578
2019
Q4
$253K Buy
90,864
+68,265
+302% +$190K ﹤0.01% 1919
2019
Q3
$34K Sell
22,599
-65,507
-74% -$98.6K ﹤0.01% 1884
2019
Q2
$183K Buy
88,106
+24,772
+39% +$51.5K ﹤0.01% 1872
2019
Q1
$227K Buy
63,334
+10,990
+21% +$39.4K ﹤0.01% 1900
2018
Q4
$200K Buy
52,344
+28,133
+116% +$107K ﹤0.01% 1871
2018
Q3
$229K Sell
24,211
-48,503
-67% -$459K ﹤0.01% 1833
2018
Q2
$531K Buy
+72,714
New +$531K ﹤0.01% 1612
2018
Q1
Sell
-42,665
Closed -$215K 1929
2017
Q4
$215K Buy
+42,665
New +$215K ﹤0.01% 2014